Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.21
-0.27 (-0.95%)
At close: Apr 10, 2026, 4:00 PM EDT
28.24
+0.03 (0.11%)
After-hours: Apr 10, 2026, 7:32 PM EDT

Roivant Sciences Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
20,1907,0228,5025,6103,4336,372
Market Cap Growth
165.18%-17.41%51.56%63.40%-46.12%-
Enterprise Value
15,7692,7252,5324,8122,0504,814
Last Close Price
28.2110.0910.547.384.949.78
PE Ratio
--42.042.02-5.20-3.92-7.64
PS Ratio
1516.90241.70259.91177.9262.10267.80
PB Ratio
4.691.501.424.852.073.54
P/TBV Ratio
4.571.561.474.542.003.43
P/FCF Ratio
--8.32-11.09-6.55-4.94-11.42
P/OCF Ratio
--8.37-11.11-6.65-5.07-11.54
EV/Sales Ratio
1184.7493.8077.41152.6137.08202.32
EV/EBITDA Ratio
--2.750.56-5.42-1.52-4.50
EV/EBIT Ratio
--2.720.56-5.31-1.52-4.50
EV/FCF Ratio
--3.23-3.30-5.62-2.95-8.63
Debt / Equity Ratio
0.020.020.010.270.130.11
Debt / EBITDA Ratio
-0.09-0.100.01-0.54-0.21-0.23
Debt / FCF Ratio
-0.14-0.12-0.07-0.56-0.41-0.44
Net Debt / Equity Ratio
-1.04-1.02-1.08-1.03-1.07-1.01
Net Debt / EBITDA Ratio
3.654.84-1.421.351.321.69
Net Debt / FCF Ratio
5.775.678.401.402.563.24
Asset Turnover
0.000.000.010.010.020.01
Quick Ratio
29.8132.7124.356.1511.189.39
Current Ratio
30.6633.4725.246.6011.649.99
Return on Equity (ROE)
-19.14%-12.54%112.87%-48.46%-44.82%-43.17%
Return on Assets (ROA)
-24.08%-16.97%93.13%-36.62%-52.26%-42.35%
Return on Invested Capital (ROIC)
-245.20%-213.53%812.38%-209.31%-338.14%-329.07%
Return on Capital Employed (ROCE)
-22.66%-16.39%99.13%-40.14%-56.65%-45.04%
Earnings Yield
-4.01%-2.38%49.62%-19.24%-25.51%-13.09%
FCF Yield
-3.80%-12.02%-9.02%-15.26%-20.25%-8.76%
Buyback Yield / Dilution
7.70%12.71%-16.59%-6.43%-6.30%1.70%
Total Shareholder Return
7.70%12.71%-16.59%-6.43%-6.30%1.70%
Updated Feb 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q